✉news TechnologyAI first seen 20 h ago, last 1 h ago, peak #16
AI firms simulate drug trials to boost human study success
Original: AI companies run virtual drug trials, aim to improve success of human studies
AI companies are now running virtual drug trials, using simulations to predict how experimental treatments might perform before real-world human testing begins. The approach aims to cut costly failures in clinical trials by identifying promising candidates earlier and flagging risks. Reuters reported the development, which adds to ongoing debate about how far artificial intelligence should be trusted in pharmaceutical research and drug development.
Why now: Growing interest in whether AI simulations can make the expensive, failure-prone drug trial pipeline more efficient.
AI companiespharmaceutical industryReuters
Rank over time, top of the chart is #1. 10 snapshots from 20 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1350271